Yep, the vet opportunity has slipped under the radar recently. At the AGM MT said they are currently doing market research to establish the potential market opportunity.
At the time I took it as meaning it was to convince BP that there is an opportunity there. But on reflection I think BP would be fully aware of the potential market. So It may be of more assistance to Pharmaust when entering negotiations. A bit like a valuation.
Divesting the program is also interesting. Sounds more like a sale than a license deal. What would be the ramifications of this ? A swag of money in the bank would certainly strengthen Pharmausts position while negotiating a MND deal.
Cheers
Ann: New Hires & Attendance at International MND Symposium, page-9
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $86.33M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.8¢ | $30.60K | 170.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 161511 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 197928 | 5 |
View Market Depth
| Last trade - 11.55am 12/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |